Show simple item record

dc.contributor.authorLourens, Anna C.U.
dc.contributor.authorGravestock, David
dc.contributor.authorVan Zyl, Robyn L.
dc.contributor.authorHoppe, Heinrich C.
dc.contributor.authorKolesnikova, Natasha
dc.date.accessioned2017-05-12T11:10:20Z
dc.date.available2017-05-12T11:10:20Z
dc.date.issued2016
dc.identifier.citationLourens, A.C.U. et al. 2016. Design, synthesis and biological evaluation of 6-aryl-1,6-dihydro-1,3,5-triazine-2,4-diamines as antiplasmodial antifolates . Organic and biomolecular chemistry, 14(33):7899-7911. [https://doi.org/10.1039/C6OB01350C]en_US
dc.identifier.issn1477-0520
dc.identifier.issn1477-0539 (Online)
dc.identifier.urihttp://hdl.handle.net/10394/21939
dc.identifier.urihttp://pubs.rsc.org/en/Content/ArticleLanding/2016/OB/C6OB01350C#!divAbstract
dc.identifier.urihttps://doi.org/10.1039/C6OB01350C
dc.description.abstractThe design, synthesis and biological evaluation of a series of 6-aryl-1,6-dihydro-1,3,5-triazine-2,4- diamines is described. These compounds exhibited in vitro antiplasmodial activity in the low nanomolar range against both drug sensitive and drug resistant strains of P. falciparum, with 1-(3-(2,4-dichlorophenoxy) propyl)-6-phenyl-1,6-dihydro-1,3,5-triazine-2,4-diamine hydrochloride identified as the most potent compound from this series against the drug resistant FCR-3 strain (IC50 2.66 nM). The compounds were not toxic to mammalian cells at therapeutic concentrations and were shown to be inhibitors of parasitic DHFR in a biochemical enzyme assayen_US
dc.language.isoenen_US
dc.publisherRSCen_US
dc.titleDesign, synthesis and biological evaluation of 6-aryl-1,6-dihydro-1,3,5-triazine-2,4-diamines as antiplasmodial antifolatesen_US
dc.typeArticleen_US
dc.contributor.researchID10948724 - Lourens, Anna Catharina U.


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record